Everninomycin (BioDeep_00000009063)

   


代谢物信息卡片


b-D-Mannopyranoside,O-(1R)-4-O-(2,4-dihydroxy-6-methylbenzoyl)-2,3-O-methylene-D-xylopyranosylidene-(1?3-4)-a-L-lyxopyranosyl O-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-a-L-arabino-hexopyranosyl-(1?3)-O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-

化学式: C70H97Cl2NO38 (1629.5065)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1C(C(CC(O1)OC2C(OC3(CC2O)OC4C(OC(C(C4(O3)C)O)OC5C(C(OC(C5OC)C)OC6C(OC(C(C6O)OC)OC7C(C8C(CO7)OC9(O8)C1C(C(CO9)OC(=O)C2=C(C=C(C=C2C)O)O)OCO1)O)COC)O)C)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])OC(=O)C1=C(C(=C(C(=C1OC)Cl)O)Cl)C
InChI: InChI=1S/C70H97Cl2NO38/c1-24-15-31(74)16-32(75)40(24)61(82)100-36-22-94-70(60-53(36)92-23-93-60)108-37-21-91-63(46(79)52(37)109-70)106-65-56(89-13)45(78)51(35(101-65)20-86-10)104-64-47(80)55(50(87-11)27(4)97-64)105-66-57(81)68(9)59(30(7)98-66)110-69(111-68)18-33(76)48(28(5)107-69)102-38-17-34(99-39-19-67(8,73(84)85)58(90-14)29(6)96-39)49(26(3)95-38)103-62(83)41-25(2)42(71)44(77)43(72)54(41)88-12/h15-16,26-30,33-39,45-53,55-60,63-66,74-81H,17-23H2,1-14H3/t26-,27-,28-,29+,30-,33-,34-,35-,36-,37+,38+,39-,45+,46-,47-,48-,49-,50+,51?,52-,53+,55+,56?,57-,58+,59-,60-,63+,64+,65+,66+,67+,68-,69?,70-/m1/s1



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 7 ALB, CLU, CST3, FABP1, MSRA, SNTB1, VIM
Peripheral membrane protein 2 CLU, SNTB1
Endoplasmic reticulum membrane 1 SPP1
Mitochondrion membrane 1 CLU
Nucleus 4 ALB, CLU, FABP1, TGFBR1
cytosol 5 ALB, CLU, FABP1, MSRA, VIM
mitochondrial membrane 1 CLU
phagocytic vesicle 1 VIM
centrosome 1 ALB
nucleoplasm 2 FABP1, MSRA
Cell membrane 4 HAVCR1, SPP1, TGFBR1, VIM
Lipid-anchor 1 MSRA
Cytoplasmic side 2 CLU, SNTB1
Multi-pass membrane protein 1 SPP1
Synapse 2 CLU, SNTB1
cell junction 1 SNTB1
cell surface 3 CLU, HAVCR1, TGFBR1
Golgi apparatus 4 ALB, CLU, CST3, SPP1
mitochondrial inner membrane 1 CLU
sarcolemma 1 SNTB1
Cytoplasm, cytosol 1 CLU
endosome 1 TGFBR1
plasma membrane 6 CST3, HAVCR1, MSRA, SPP1, TGFBR1, VIM
Membrane 2 MSRA, TGFBR1
axon 1 VIM
extracellular exosome 9 ALB, CLU, CST3, FABP1, LCN2, MSRA, RBP4, SPP1, VIM
endoplasmic reticulum 3 ALB, CLU, CST3
extracellular space 7 ALB, ARTN, CLU, CST3, LCN2, RBP4, SPP1
perinuclear region of cytoplasm 2 CLU, SPP1
Cell junction, tight junction 1 TGFBR1
bicellular tight junction 1 TGFBR1
mitochondrion 2 CLU, MSRA
protein-containing complex 4 ALB, CLU, FABP1, SNTB1
intracellular membrane-bounded organelle 2 CLU, MSRA
Single-pass type I membrane protein 2 HAVCR1, TGFBR1
Secreted 7 ALB, ARTN, CLU, CST3, LCN2, RBP4, SPP1
extracellular region 7 ALB, ARTN, CLU, CST3, LCN2, RBP4, SPP1
Cytoplasmic vesicle lumen 1 LCN2
anchoring junction 1 ALB
motile cilium 1 HAVCR1
actin cytoskeleton 1 MSRA
midbody 1 MSRA
vesicle 1 CST3
Cell membrane, sarcolemma 1 SNTB1
Cytoplasm, perinuclear region 1 CLU
Membrane raft 1 TGFBR1
Cytoplasm, cytoskeleton 2 SNTB1, VIM
focal adhesion 2 SNTB1, VIM
Peroxisome 1 VIM
peroxisomal matrix 1 FABP1
collagen-containing extracellular matrix 1 CLU
intermediate filament 1 VIM
receptor complex 1 TGFBR1
neuron projection 1 VIM
ciliary basal body 1 ALB
cell leading edge 1 VIM
cell projection 1 SPP1
cytoskeleton 2 SNTB1, VIM
centriole 1 ALB
spindle pole 1 ALB
blood microparticle 2 ALB, CLU
microtubule organizing center 1 VIM
intermediate filament cytoskeleton 1 VIM
[Isoform 4]: Cytoplasm 1 CLU
Microsome 1 CLU
ficolin-1-rich granule lumen 1 CST3
endoplasmic reticulum lumen 3 ALB, CST3, SPP1
nuclear matrix 1 VIM
platelet alpha granule lumen 2 ALB, CLU
specific granule lumen 1 LCN2
tertiary granule lumen 1 CST3
Nucleus matrix 1 VIM
apical dendrite 1 CLU
dystrophin-associated glycoprotein complex 1 SNTB1
spherical high-density lipoprotein particle 1 CLU
[Isoform 1]: Secreted 1 CLU
apical cortex 1 FABP1
neurofibrillary tangle 1 CLU
Cytoplasmic vesicle, secretory vesicle, chromaffin granule 1 CLU
chromaffin granule 1 CLU
[Isoform 6]: Cytoplasm 1 CLU
perinuclear endoplasmic reticulum lumen 1 CLU
activin receptor complex 1 TGFBR1
transforming growth factor beta ligand-receptor complex 1 TGFBR1
ciliary transition fiber 1 ALB
Cytoplasmic granule lumen 1 LCN2


文献列表

  • John W Davis, Federico M Goodsaid, Christopher M Bral, Leslie A Obert, George Mandakas, C Edwin Garner, Nathaniel D Collins, Roger J Smith, I Y Rosenblum. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicology and applied pharmacology. 2004 Oct; 200(1):16-26. doi: 10.1016/j.taap.2004.02.001. [PMID: 15451304]
  • Satoru Nagashima, Masayuki Niwa, Katsuyuki Nishiki, Tatsuo Hosoya, Akira Hishida, Toshihiko Uematsu. Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans. European journal of clinical pharmacology. 2004 Jun; 60(4):255-64. doi: 10.1007/s00228-004-0755-y. [PMID: 15088132]
  • Ruyun Zhong, Abraham Hernandez, Kevin B Alton, Narendra S Kishnani, James E Patrick. High-performance liquid chromatographic method for the quantification of unbound evernimicin in human plasma ultrafiltrate. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2002 May; 772(1):191-5. doi: 10.1016/s1570-0232(02)00084-3. [PMID: 12016032]
  • O Kozawa, T Uematsu, H Matsuno, M Niwa, K Kohno, A Kawato, K Takahashi, S Nagashima, M Kanamaru. Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects. Antimicrobial agents and chemotherapy. 2001 Mar; 45(3):917-21. doi: 10.1128/aac.45.3.917-921.2001. [PMID: 11181380]
  • E Wang, M Simard, Y Bergeron, D Beauchamp, M G Bergeron. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. Antimicrobial agents and chemotherapy. 2000 Apr; 44(4):1010-8. doi: 10.1128/aac.44.4.1010-1018.2000. [PMID: 10722505]
  • C Lin, S Gupta, D Loebenberg, M N Cayen. Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration. Antimicrobial agents and chemotherapy. 2000 Apr; 44(4):916-9. doi: 10.1128/aac.44.4.916-919.2000. [PMID: 10722491]
  • C C Lin, C Korduba, D Parker. Simple and sensitive high-performance liquid chromatographic method for the determination of an everninomycin, SCH 27899, in rat plasma. Journal of chromatography. B, Biomedical sciences and applications. 1999 Jun; 730(1):55-9. doi: 10.1016/s0378-4347(99)00204-2. [PMID: 10437672]
  • W E Sanders, C C Sanders. Microbiological characterization of everninomicins B and D. Antimicrobial agents and chemotherapy. 1974 Sep; 6(3):232-8. doi: 10.1128/aac.6.3.232. [PMID: 15830468]